News

Collaboration with Ludwig Cancer Research.

April 21, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Ludwig Cancer Research Center on a series of clinical proteomics projects.

Ludwig Cancer Research is an international community of scientists focused on cancer research, with the goals of preventing and controlling cancer. It encompasses the Ludwig Institute for Cancer Research, an international non-profit organization founded in 1971 by philanthropist Daniel K. Ludwig. The Institute is headquartered in New York City with a European office located in Zurich. In addition, six Ludwig Centers were established at leading US cancer research institutions. Together, the Institute and Centers are known as Ludwig Cancer Research.

Since its founding in 1971, Ludwig Cancer Research has committed more than (US) $2.5 billion to cancer research. Ludwig Cancer Research focuses on both basic research and translational research, with specific emphasis on cell biology, genomics, immunology, neuroscience, prevention, cell signaling, stem cells, therapeutics, and tumor biology, as well as clinical trials and the design and development of small molecules with drug-like properties. Its researchers also focus on particular types of malignancy, including brain cancer, breast cancer, colon cancer, and melanoma.

Follow by Email
Facebook
Twitter
LinkedIn